Talphera Inc News Today

Talphera, Inc. (NASDAQ:TLPH – Get Free Report) saw a large decline in short interest during the month of May. As of May 15th, there was short interest totalling 121,200 shares, a decline of 17.7% from the April 30th total of 147,300 shares. Based on an average daily volume of 76,100 shares, the short-interest ratio is […]

SAN MATEO, Calif., May 20, 2024 /PRNewswire/ -- Talphera, Inc. , , a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically...

HC Wainwright reiterated their buy rating on shares of Talphera (NASDAQ:TLPH – Free Report) in a research note issued to investors on Wednesday, Benzinga reports. They currently have a $6.00 price objective on the stock. HC Wainwright also issued estimates for Talphera’s Q2 2024 earnings at ($0.22) EPS, Q3 2024 earnings at ($0.21) EPS, FY2024 […]

HC Wainwright restated their buy rating on shares of Talphera (NASDAQ:TLPH – Free Report) in a research report sent to investors on Wednesday, Benzinga reports. The firm currently has a $6.00 target price on the stock. Separately, Maxim Group started coverage on Talphera in a report on Monday, May 6th. They issued a buy rating […]

HC Wainwright reissued their buy rating on shares of Talphera (NASDAQ:TLPH – Free Report) in a research note published on Wednesday, Benzinga reports. HC Wainwright currently has a $6.00 target price on the stock. Separately, Maxim Group started coverage on Talphera in a research report on Monday, May 6th. They issued a buy rating and […]

/PRNewswire/ -- Talphera, Inc. (Nasdaq: TLPH), ("Talphera"), a specialty pharmaceutical company focused on the development and commercialization of innovative...

XOMA acquires Kinnate Biopharma for $2.3352 per share, with potential additional cash. The acquisition is expected to close in April 2024.

Talphera (NASDAQ:TLPH – Get Free Report) is one of 984 publicly-traded companies in the “Pharmaceutical preparations” industry, but how does it weigh in compared to its rivals? We will compare Talphera to related businesses based on the strength of its valuation, institutional ownership, risk, analyst recommendations, profitability, dividends and earnings. Analyst Recommendations This is a […]

Shares of Sintx Technologies, Inc. (NASDAQ: SINT) rose sharply in today’s pre-market trading after the company announced its subsidiary Technology Assessment & Transfer entered into a Cooperative Research and Development agreement with the U.S.

Talphera, Inc. (NASDAQ:TLPH – Free Report) – Equities researchers at HC Wainwright decreased their FY2023 earnings per share (EPS) estimates for Talphera in a research note issued to investors on Monday, January 22nd. HC Wainwright analyst E. Arce now forecasts that the company will earn ($0.55) per share for the year, down from their previous […]